Literature DB >> 32002400

3D WrapTM Ultra-Widefield Reconstruction in Stereotactic Radiosurgery for Choroidal Melanoma.

Maria Vittoria Cicinelli1, Alessandro Marchese1, Francesco Bandello1, Giulio Maria Modorati1.   

Abstract

Choroidal melanoma (CM) is the most commonly diagnosed primary intraocular malignancy in adults. Gamma knife radiosurgery (GKR) has demonstrated reliable results in the treatment of CM, but it is limited by the risk of radiation-induced ocular complications. To optimize the dose of radiation focused on the tumor, and limit side effects, the eye should be properly immobilized before treatment. A recently released ultra-widefield imaging instrument (Optomap California; Optos, Dunfermline, Scotland, UK) allows for an interactive three-dimensional (3D) virtual reconstruction of the globe, called 3D Wrap<sup>TM</sup>. The authors share their experience with this rapid, reliable, and relatively easy support in planning globe positioning before GKR treatment.
Copyright © 2019 by S. Karger AG, Basel.

Entities:  

Keywords:  Choroidal melanoma; Gamma knife radiosurgery; Ultra-widefield imaging

Year:  2019        PMID: 32002400      PMCID: PMC6984162          DOI: 10.1159/000500312

Source DB:  PubMed          Journal:  Ocul Oncol Pathol        ISSN: 2296-4657


  21 in total

1.  Influence of single-fraction Gamma-Knife radiosurgery on ocular surface and tear function in choroidal melanoma patients.

Authors:  Jutta Horwath-Winter; Mona Regina Schneider; Werner Wackernagel; Dieter Rabensteiner; Ingrid Boldin; Eva-Maria Haller-Schober; Gerald Langmann
Journal:  Br J Ophthalmol       Date:  2013-01-24       Impact factor: 4.638

2.  Gamma Knife Stereotactic Radiosurgery for the Treatment of Primary and Metastatic Ocular Malignancies.

Authors:  Andrea L H Arnett; Margaret M Reynolds; Jose S Pulido; Ian F Parney; Nadia N Laack
Journal:  Stereotact Funct Neurosurg       Date:  2017-11-04       Impact factor: 1.875

3.  Local tumor control and morbidity after one to three fractions of stereotactic external beam irradiation for uveal melanoma.

Authors:  M Zehetmayer; K Kitz; R Menapace; A Ertl; H Heinzl; I Ruhswurm; M Georgopoulos; K Dieckmann; R Pötter
Journal:  Radiother Oncol       Date:  2000-05       Impact factor: 6.280

4.  Gamma knife radiosurgery for uveal melanomas: an 8-year experience.

Authors:  G Langmann; G Pendl; G Papaefthymiou; H Guss
Journal:  J Neurosurg       Date:  2000-12       Impact factor: 5.115

Review 5.  Uveal melanoma: relatively rare but deadly cancer.

Authors:  S Kaliki; C L Shields
Journal:  Eye (Lond)       Date:  2016-12-02       Impact factor: 3.775

6.  Predictors of radio-induced visual impairment after radiosurgery for uveal melanoma.

Authors:  Carmen Rosaria Gigliotti; Giulio Modorati; Maura Di Nicola; Claudio Fiorino; Lucia Alessia Perna; Elisabetta Miserocchi; Alberto Franzin; Piero Picozzi; Angelo Bolognesi; Pietro Mortini; Antonella Del Vecchio; Riccardo Calandrino
Journal:  Br J Ophthalmol       Date:  2017-09-13       Impact factor: 4.638

7.  Choroidal pigmented lesions imaged by ultra-wide-field scanning laser ophthalmoscopy with two laser wavelengths (Optomap).

Authors:  Marcus Kernt; Ulrich C Schaller; Carmen Stumpf; Michael W Ulbig; Anselm Kampik; Aljoscha S Neubauer
Journal:  Clin Ophthalmol       Date:  2010-07-30

8.  Incidence of uveal melanoma in Europe.

Authors:  Gianni Virgili; Gemma Gatta; Laura Ciccolallo; Riccardo Capocaccia; Annibale Biggeri; Emanuele Crocetti; Jean-Michel Lutz; Eugenio Paci
Journal:  Ophthalmology       Date:  2007-05-11       Impact factor: 12.079

9.  Local tumour control and eye preservation after gamma-knife radiosurgery of choroidal melanomas.

Authors:  Werner Wackernagel; Etienne Holl; Lisa Tarmann; Christoph Mayer; Alexander Avian; Mona Schneider; Karin S Kapp; Gerald Langmann
Journal:  Br J Ophthalmol       Date:  2013-10-29       Impact factor: 4.638

10.  Visual acuity after Gamma-Knife radiosurgery of choroidal melanomas.

Authors:  Werner Wackernagel; Etienne Holl; Lisa Tarmann; Alexander Avian; Mona Regina Schneider; Karin Kapp; Gerald Langmann
Journal:  Br J Ophthalmol       Date:  2012-11-07       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.